I believe that the preference has always been to use Cell-Pryme A as a neoadjuvant.
According to the patent, Cell-Pryme A should be administered at least 18 hours prior to CAR-T, dendritic cells or NK cells being administered.
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022241515&_cid=P11-LP80EH-30307-1
- Forums
- ASX - By Stock
- PTX
- Pitt St Research Report...
Pitt St Research Report..., page-11
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.2¢ | $4.464K | 106.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7343 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 403472 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 350595 | 0.041 |
8 | 468294 | 0.040 |
8 | 657589 | 0.039 |
6 | 738222 | 0.038 |
9 | 883000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 200000 | 1 |
0.044 | 375807 | 3 |
0.045 | 423919 | 4 |
0.046 | 198002 | 2 |
0.047 | 613389 | 3 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online